Hepatic fibrogenesis requires sympathetic neurotransmitters.
about
Beta-adrenergic receptor 1 selective antagonism inhibits norepinephrine-mediated TNF-alpha downregulation in experimental liver cirrhosisLiver fibrosisHepatic stellate cells: protean, multifunctional, and enigmatic cells of the liverMechanisms of hepatic fibrogenesisβ-Adrenoceptor blockade in sclerosing cholangitis of Mdr2 knockout mice: antifibrotic effects in a model of nonsinusoidal fibrosis.Maternal obesity programmes offspring development of non-alcoholic fatty pancreas diseaseAlpha-1 adrenergic receptor transactivates signal transducer and activator of transcription-3 (Stat3) through activation of Src and epidermal growth factor receptor (EGFR) in hepatocytes.Principles of liver regeneration and growth homeostasis.Role of serotonin in development of esophageal and gastric fundal varices.Selective α1B- and α1D-adrenoceptor antagonists suppress noradrenaline-induced activation, proliferation and ECM secretion of rat hepatic stellate cells in vitro.Genetic covariance between gamma-glutamyl transpeptidase and fatty liver risk factors: role of beta2-adrenergic receptor genetic variation in twins.Protective effects of hypothalamic beta-endorphin neurons against alcohol-induced liver injuries and liver cancers in rat animal modelsSympathetic nervous system catecholamines and neuropeptide Y neurotransmitters are upregulated in human NAFLD and modulate the fibrogenic function of hepatic stellate cells.Hepatic stellate cells and astrocytes: Stars of scar formation and tissue repair.The stress-related hormone norepinephrine induced upregulation of Nix, contributing to ECM protein expression.M1 Muscarinic Receptor Deficiency Attenuates Azoxymethane-Induced Chronic Liver Injury in Mice.Metabolic dysfunction in obstructive sleep apnea: A critical examination of underlying mechanismsAutonomic dysregulation as a novel underlying cause of mitral valve prolapse: a hypothesisOsteopontin is a proximal effector of leptin-mediated non-alcoholic steatohepatitis (NASH) fibrosis.Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: implications for treatment.Hepatic nervous system and neurobiology of the liver.Cholangiocyte proliferation and liver fibrosis.Surgical denervation of ocular sympathetic afferents decreases local transforming growth factor-beta and abolishes immune privilegeSignals and cells involved in regulating liver regeneration.Propranolol, a β-adrenoceptor antagonist, worsens liver injury in a model of non-alcoholic steatohepatitisTranslating an understanding of the pathogenesis of hepatic fibrosis to novel therapiesThe β-adrenoceptor agonist isoproterenol rescues acetaminophen-injured livers through increasing progenitor numbers by Wnt in mice.Roles of phosphatidylinositol 3-kinase and osteopontin in steatosis and aminotransferase release by hepatocytes treated with methionine-choline-deficient medium.Role for hedgehog signaling in hepatic stellate cell activation and viability.Practical management of the increasing burden of non-alcoholic fatty liver disease.Doxazosin Treatment Attenuates Carbon Tetrachloride-Induced Liver Fibrosis in Hamsters through a Decrease in Transforming Growth Factor β Secretion.Nerve-cancer interactions in the stromal biology of pancreatic cancer.The effect of adrenal medullectomy on metabolic responses to chronic intermittent hypoxia.The alpha2-adrenergic receptor agonist UK 14,304 inhibits secretin-stimulated ductal secretion by downregulation of the cAMP system in bile duct-ligated rats.Carvedilol attenuates the progression of alcohol fatty liver disease in rats.Reappraisal of Antihypertensive Medicine Doxazosin and Carvedilol as a Potential Therapeutic for Hepatic Fibrosis.Amphiregulin activates human hepatic stellate cells and is upregulated in non alcoholic steatohepatitis.Role of beta3-adrenoceptors for intrahepatic resistance and portal hypertension in liver cirrhosis.Stem cells in the development and differentiation of the human adrenal glands.Precision-cut liver slices as a new model to study toxicity-induced hepatic stellate cell activation in a physiologic milieu.
P2860
Q27323077-36900877-1080-4ECA-9AC9-9D846CF76EB8Q29547449-D937A836-D25F-4B46-AF61-E4C6D3212969Q29616840-47766A8C-075C-475C-A108-EC04844C60F6Q29619336-77A3F1CD-E92E-4999-9D13-9BD7EBA35BAFQ33710554-84B6BCF2-1C7E-4B1F-906D-358DF18291E0Q33882340-A622D46E-A771-45A4-9632-9E5FEA73009EQ33919595-70E4D56F-A93F-42E7-8F63-8C52F1DE9938Q34347580-70C76C5F-E9E9-456E-BCDE-4BDE10D70CA8Q34450683-8B41C484-FE9B-4960-A48E-28D34E4F4C06Q34451955-2C0CB421-648A-43C3-B883-EB44F95D2393Q34572645-BBDAB501-FB27-4947-838E-CC3F573C4093Q34941380-8E7E3EFF-CAA7-4DE1-89E5-10C0B5A1A690Q34982754-DBD65BAD-8D7A-4567-BE0A-28A57B64FD02Q35124593-549457F7-0442-4DAE-84F5-38EC77DDC2BDQ35319620-AA8947A5-B00E-42AF-B87C-2387B492E124Q36064546-6ECE3E7B-8C91-456A-88F5-E148816E654DQ36093354-4F708BFA-86B1-4EF9-A22B-FA51919EAA8AQ36576608-0C5FEA64-D7F0-4AB6-88E3-B46ABD154011Q36588292-036B3E56-B0E6-4A8D-9D1A-825401D7BE44Q37051418-565FD624-A4DF-479C-A727-8FB265E5961AQ37068849-91E4E99A-4C36-45CE-87E1-F7428BB48A33Q37175438-E531B217-E5EE-4548-BFFF-753A18F08C29Q37316544-1F73C5F8-49B7-4576-B50E-1EACFE2AE41AQ37512367-5064551C-A1BC-4122-B63B-59289CD2C032Q37580758-7E8A4DC7-279A-49F7-9F65-F76892C21A07Q38073028-DAF25663-A2A4-4558-808D-B0C88CEBDA4AQ38985481-42450987-F739-48DD-A3F6-CC9594E2E6FEQ40324567-DA3E942C-1713-495E-9958-5C8195DD2F7CQ40371810-15E77191-4D5A-4995-9032-EC6DE938B162Q41059980-56C37248-7DF2-4E38-8E65-72A0DE100673Q41551456-05869AE4-3A70-4B22-9027-ED1FC85F1802Q41953936-1C9B81A7-FD71-4D5A-92DE-8E7D7B9C85DAQ42082788-8CE00809-FB31-4083-BBDB-0BA7B585AA17Q42515925-4D9640C9-BAE4-4155-8A5C-691879801213Q42720548-C896973C-9F20-42E7-BFD0-577596E54B43Q43112564-E061712B-A162-485C-AD29-CCB2DBAFEDCCQ43178467-CE295F0A-5430-41F9-8FA6-4C1A081EA22FQ43258430-A9C2FC7D-0DAC-46E9-8D15-D9F64F214CA1Q44366903-E7CF0F0B-414D-4F9B-98C7-285893962F66Q45280998-1924754A-AEC9-4CB8-9053-5F12F32D90C0
P2860
Hepatic fibrogenesis requires sympathetic neurotransmitters.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Hepatic fibrogenesis requires sympathetic neurotransmitters.
@ast
Hepatic fibrogenesis requires sympathetic neurotransmitters.
@en
type
label
Hepatic fibrogenesis requires sympathetic neurotransmitters.
@ast
Hepatic fibrogenesis requires sympathetic neurotransmitters.
@en
prefLabel
Hepatic fibrogenesis requires sympathetic neurotransmitters.
@ast
Hepatic fibrogenesis requires sympathetic neurotransmitters.
@en
P2093
P2860
P356
P1433
P1476
Hepatic fibrogenesis requires sympathetic neurotransmitters.
@en
P2093
M Torbenson
S A Thomas
P2860
P304
P356
10.1136/GUT.2003.026658
P407
P577
2004-03-01T00:00:00Z